ClearPoint Neuro Operating Margin 2010-2024 | CLPT
Current and historical operating margin for ClearPoint Neuro (CLPT) over the last 10 years. The current operating profit margin for ClearPoint Neuro as of December 31, 2024 is -60.26%.
| ClearPoint Neuro Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-12-31 |
$0.03B |
$-0.02B |
-62.50% |
| 2024-09-30 |
$0.03B |
$-0.02B |
-61.29% |
| 2024-06-30 |
$0.03B |
$-0.02B |
-65.52% |
| 2024-03-31 |
$0.03B |
$-0.02B |
-77.78% |
| 2023-12-31 |
$0.02B |
$-0.02B |
-95.83% |
| 2023-09-30 |
$0.02B |
$-0.02B |
-100.00% |
| 2023-06-30 |
$0.02B |
$-0.02B |
-100.00% |
| 2023-03-31 |
$0.02B |
$-0.02B |
-90.00% |
| 2022-12-31 |
$0.02B |
$-0.02B |
-80.00% |
| 2022-09-30 |
$0.02B |
$-0.02B |
-84.21% |
| 2022-06-30 |
$0.02B |
$-0.02B |
-84.21% |
| 2022-03-31 |
$0.02B |
$-0.02B |
-88.24% |
| 2021-12-31 |
$0.02B |
$-0.01B |
-81.25% |
| 2021-09-30 |
$0.02B |
$-0.01B |
-68.75% |
| 2021-06-30 |
$0.02B |
$-0.01B |
-53.33% |
| 2021-03-31 |
$0.01B |
$-0.01B |
-42.86% |
| 2020-12-31 |
$0.01B |
$-0.01B |
-38.46% |
| 2020-09-30 |
$0.01B |
$0.00B |
-33.33% |
| 2020-06-30 |
$0.01B |
$0.00B |
-36.36% |
| 2020-03-31 |
$0.01B |
$0.00B |
-33.33% |
| 2019-12-31 |
$0.01B |
$0.00B |
-36.36% |
| 2019-09-30 |
$0.01B |
$0.00B |
-40.00% |
| 2019-06-30 |
$0.01B |
$0.00B |
-44.44% |
| 2019-03-31 |
$0.01B |
$-0.01B |
-62.50% |
| 2018-12-31 |
$0.01B |
$-0.01B |
-62.50% |
| 2018-09-30 |
$0.01B |
$-0.01B |
-75.00% |
| 2018-06-30 |
$0.01B |
$-0.01B |
-75.00% |
| 2018-03-31 |
$0.01B |
$-0.01B |
-75.00% |
| 2017-12-31 |
$0.01B |
$-0.01B |
-75.00% |
| 2017-09-30 |
$0.01B |
$-0.01B |
-75.00% |
| 2017-06-30 |
$0.01B |
$-0.01B |
-87.50% |
| 2017-03-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2016-12-31 |
$0.01B |
$-0.01B |
-133.33% |
| 2016-09-30 |
$0.01B |
$-0.01B |
-116.67% |
| 2016-06-30 |
$0.01B |
$-0.01B |
-140.00% |
| 2016-03-31 |
$0.01B |
$-0.01B |
-160.00% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-180.00% |
| 2015-09-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2015-06-30 |
$0.00B |
$-0.01B |
-300.00% |
| 2015-03-31 |
$0.00B |
$-0.01B |
-275.00% |
| 2014-12-31 |
$0.00B |
$-0.01B |
-150.00% |
| 2014-09-30 |
$0.00B |
$-0.01B |
-125.00% |
| 2014-06-30 |
$0.00B |
$0.00B |
-100.00% |
| 2014-03-31 |
$0.00B |
$0.00B |
-100.00% |
| 2013-12-31 |
$0.00B |
$-0.01B |
-175.00% |
| 2013-09-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2013-06-30 |
$0.01B |
$0.00B |
-80.00% |
| 2013-03-31 |
$0.01B |
$0.00B |
-40.00% |
| 2012-12-31 |
$0.01B |
$0.00B |
-40.00% |
| 2012-09-30 |
$0.00B |
$0.00B |
-75.00% |
| 2012-06-30 |
$0.00B |
$0.00B |
-75.00% |
| 2012-03-31 |
$0.00B |
$0.00B |
-100.00% |
| 2011-12-31 |
$0.00B |
$-0.01B |
-125.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.404B |
$0.031B |
|
ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.
|
